The Nanomed Zone – EVO-NANO article
EVO-NANO was recently invited by a fellow website, The Nanomed Zone, to pen an opinion piece on the COVID-19 outbreak and the potential role nanomedicines can play in novel pandemics. …
Research Spotlight (UWE) – Novelty search employed into the development of cancer treatment simulations
https://www.sciencedirect.com/science/article/pii/S2352914820301714 A team of members from the University of the West of England and the University of Novi Sad have come out with a paper in Informatics in Medicine Unlocked …
Cancer, Evolution, ALife – May 27th 2020
Due to the COVID-19 pandemic, EVO-NANO is taking the step towards teleconferencing and moving our workshop (intended for April 2020) to an online platform. We are aiming to produce a …
Research Spotlight (ProChimia) – Targeted crystallization of mixed-charge nanoparticles induces cancer cell death
Our research partners at ProChimia have recently been involved in a breakthrough paper where nanoparticles have selectively killed cancer cells in vitro without using any toxic anti-cancer agents. The paper, …
EVO-NANO @ NALS2020 (Madrid)
Over the 29th to the 31st of January, the 2nd International Conference on Nanomaterials Applied to Life Sciences 2020 took place in Madrid, Spain. This conference was organized by our …
Research Spotlight (VHIR): Anti-cancer drug delivery in polymeric micelles
Click to read the full press release on the VHIR website Our EVO-NANO colleagues at the Vall d’Hebron Institut de Recerca have recently published work in connection with our project …
Brainstorming in Brussels (18th Nov 2019)
Monday the 18th marked the start of our two-day meeting in the lovely (if freezing cold) city of Brussels, Belgium. The EVO-NANO team met at the UK Research Office on …
Presenting to the EU Commission (19 Nov 2019)
Tuesday’s meeting at the EU Commission was a long day of presentations to a panel of four expert monitors, as well as our EU Project Officer. We assembled in the …
EVO-NANO @ Horizon Health (Cambridge)
As a top figure at Vall d’Hebron Research Institute (VHIR) Dr. Simó Schwartz Jr. recently attended the Health Horizons: Future Healthcare Forum. While there, he acted as part of a …